Roquette opens health and pharma solutions innovation center in Brazil
This new facility strengthens Latin America as a collaborative hub
This new facility strengthens Latin America as a collaborative hub
With this expansion, the overall fermentation capacity of the company has increased from 450 KL to 990 KL
Zaltenibart offers best-in-class potential across multiple rare blood and kidney disorders, enhancing Novo Nordisk’s rare disease portfolio
Treatment with TUKYSA was well-tolerated, with a safety profile consistent with previously known profiles of the individual agents
Acquisition aims to strengthen Merck's downstream process offering of advanced filtration and chromatography solutions
IND clearance enables initiation of Phase 1c clinical trial in HFpEF patients with elevated endotrophin levels
This innovation reinforces Fredun's commitment to creating a 360 degree pet wellness ecosystem
Subscribe To Our Newsletter & Stay Updated